Spinal muscular atrophy (SMA), a frequent neurodegenerative disease, is caused by reduced levels of functional SMN protein. SMN is involved in multiple pathways including RNA metabolism and splicing as well as motoneuron development and function. Here we provide evidence for a major contribution of the Rho-kinase (ROCK) pathway in SMA pathogenesis.
INTRODUCTION
Proximal spinal muscular atrophy (SMA) is a devastating neuromuscular disease leading to a progressive degeneration of the -motoneurons in the spinal cord (1) . With an incidence of 1-6,000 to 1-10,000 and a carrier frequency of 1:35 in the Caucasian population SMA is one of the most common autosomal recessive disorder which leads to an early death in childhood (2) (3) (4) . SMA is caused by deletion, gene conversion or subtle mutation of the survival of motoneuron 1 (SMN1) gene encoding the SMN protein (5) . A second SMN gene, SMN2, modifies the severity of the disease by expressing a small amount of full-length and functional SMN protein; a higher copy number of SMN2 results in milder SMA phenotypes termed SMA type II, III and IV (6, 7) . The 40 kDa ubiquitously expressed SMN protein acts as an assembly factor for small nuclear ribonuclear protein particles (snRNPs) or small nucleolar RNPs (snoRNPs) involved in splicing (8) (9) (10) . In the nucleus, SMN is found in nuclear foci (11). Several SMN mutations identified in SMA patients disrupt in vitro the binding of SMN to Smith (Sm) antigen proteins, which are components of snRNPs (12). However, no splicing defects are found in presymptomatic stages which are linked to motoneuron death (13). outgrowth defects are accompanied by a hyperstabilization of actin-filaments. Interestingly, others have found concentration of F-actin around the cell body perimeter in SMN knockdown cells, accompanied by accumulation of GAP-43 in membrane ruffles and neurofilaments in swellings of neurites (25) . The dynamics of actin cytoskeleton at growth cones in neurons is the driving force of neurite extension. A functional association of SMN with actin-regulatory proteins has been previously reported to upregulate the actin binding protein profilin2a in SMA cells (25, 26) . Profilin2a promotes actin polymerization and is a downstream target of Rho-Kinase 2 in the Rho-Kinase (ROCK) pathway, which becomes inhibited during neuronal differentiation (27) (28) (29) . Additionally, it has been shown that application of the ROCK inhibitor Y27632 rescues SMA symptoms in an intermediate mouse model for SMA. Here, lifespan was prolonged significantly, maturation of the neuromuscular junction improved and muscle fiber size increased (30). Importantly, these data underscore the therapeutic potential of ROCK inhibition in SMA. SMN colocalizes with profilin2a in neurite-like extensions (31) . The SMN protein sequence exhibits a poly-proline domain in exon 5 which is assumed to be the binding site of profilin2a (32) . In the present study, we characterized the interaction between profilin2a and SMN in a cellular system using a new protein interaction method. With this system, we were able to determine the profilin2a binding domain in the SMN protein. Interestingly, we found that a newly identified SMN patient mutation located next to the binding domain abolished profilin2a binding to SMN.
Additionally, we show that ROCK-downstream targets become regulated in SMA by differential phosphorylation. Loss of SMN resulted in hyper-phosphorylation of profilin2a thereby repressing neurite outgrowth in neuronal cells. These results demonstrate that SMN interferes with the ROCK pathway via profilin2a and provides a mechanistic basis to explain axonal defects in SMA pathogenesis.
RESULTS

The actin cytoskeleton in growth cones of SMA motoneurons becomes dysregulated
We have previously shown that SMN regulates neurite outgrowth in PC12 cells and modulates β-actin dynamics, a driving force of neurite outgrowth. In lysates of these cells, a hyperstabilization of actin filaments has been detected by a centrifugation assay (22) . To test whether this is also present in SMA motoneurons, we here determined the ratio of filamentous F-actin to globular G-actin in growth cones of explanted motoneurons from SMA mice and controls by fluorescence staining of both actin forms. In a preceding control experiment in PC12 cells, the fluorescence assay showed increase of F-actin after SMN knock-down ( Fig.   S1 ) and confirmed our previous biochemical results (22). Motoneurons were first explanted at embryonic stage E14 from SMA7 and control mice and then cultivated on collagen I. After quantification of the fluorescent Phalloidin signal for F-actin and DNaseI signal for G-actin in the growth cones, F-/G-actin ratios were calculated (Fig. 1) . The result showed that the F-/Gactin ratio was significantly increased in SMA motoneurons in comparison to controls. Next, we asked whether this dysregulation is motoneuron-specific or a general observation. We analyzed the F-/G-actin ratios by means of a biochemical centrifugation assay in a number of primary fibroblast cell lines obtained from SMA patients and healthy controls (Fig. S2A-D) .
The results reveal no differences between fibroblasts from patients and controls. This argues that the observed dysregulation of the actin cytoskeleton is restricted to neuronal cells. This is an important finding since only a few neuron-specific consequences of SMN-loss have been described previously.
6
SMN binds to profilin2a in vivo
Actin assembly is promoted by the actin-binding proteins profilin1 and profilin2a. The latter is the neuronal isoform of profilin. A SMN-profilin2a interaction has been previously demonstrated, however, a direct interaction in vivo has not been shown yet (30-32). To determine whether SMN and profilin2a are interacting in the motoneuron cell line NSC34, we used a new interaction assay based on SUMOylation of proteins, a posttranslational modification of substrate proteins mediated by the SUMO-conjugating enzyme Ubc9. In this method, called the trans-SUMOylation (TRS) system (33), the putative binding partner is fused to Ubc9 and coexpressed with SUMO1 as well as the protein of interest. An interaction between the proteins tethers the fused Ubc9 in close proximity to the interactor and results in its trans-SUMOylation (Fig. S3A) . Hence, trans-SUMOylation reflects the binding of these
proteins. An advantage of this system is the detection of in vivo protein interactions (33) .
To study the SMN-profilin2a interaction, profilin2a was fused to Ubc9 and coexpressed with EGFP-SUMO and SMN-EGFP. For negative control, cells were transfected with Ubc9 instead of Ubc9-profilin2a. After 24h of coexpression, we detected SUMOylated SMN-EGFP in the extracts analyzed by western blotting (Fig. 2A) . SUMOylated SMN migrated slower in SDS-PAGE ( Fig. 2A, lane 5; Fig. S3B ). As an additional control, SUMOylation of SMN was performed with non-fused SUMO (Fig. S3B, lane 4) . As a negative control, expressing Ubc9 alone instead of the fusion protein Ubc9-profilin2a did not result in SUMOylated SMN ( Fig.   2A , lane 4). Endogenous SMN was not SUMOylated (Fig. 2A, lane 6 ) possibly due to lack of modifiable sites. Instead, EGFP in the SMN-EGFP fusion protein was probably the target for the trans-SUMOylation. Moreover, SMN expression levels were comparable between lanes (Fig. 2B) . Hence, the in vivo SUMOylation by tethering Ubc9 in close contact to a protein of interest is a specific indicator for the interaction of SMN with profilin2a.
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Profilin2a binding to SMN is disrupted by a SMA-patient mutation
Profilins bind to prolin-rich sequences (32) . In SMN, three proline-rich stretches are present in the sequence encoded by exon 5. To determine the profilin2a binding site, we generated a mutant for each proline stretch denoted as P1 (P196-198A), P2 (P219-224A) and P3 (P245-247A) by converting 3-5 proline to alanine residues. Expression of the proline mutants was first tested in HEK293 cells to check for normal distribution in the nucleus and in growth cones of NSC34 cells (Fig. 3A) . SMN and proline-mutants were located in nuclear bodies and in the perinuclear cytoplasm as well as in the growth cones. The proline mutants showed no change of the SMN distribution in comparison to the wild-type. Then, binding of profilin2a to the SMN mutants was determined in the SUMOylation assay. The analysis showed that the mutation in the first (P1) and in the third (P3) domain did not affect profilin2a binding (Fig.   3B ). However, mutations in the second domain (P2) disrupted consistently this interaction reflected by a decrease of SMN trans-SUMOylation. We conclude that the P2 proline stretch is important for binding of profilin2a.
Next, we analyzed whether loss of the profilin2a binding is linked to SMA pathogenesis. Therefore, we generated five point mutants (W92S, E134K, S230L, Y272C, T274I) which harbour SMN missense mutations of SMA patients. S230L is a novel missense mutation in the SMN2 gene (c.689C>T) of a SMA type II patient with two copies of SMN2 (Fig. S4) .
Expression of the mutants in NSC34 cells revealed no change of SMN distributions in comparison to the wild type (Fig. S5) . Then, we performed the SUMOylation assay to determine whether the mutation has an impact on the interaction with profilin2a. The analysis revealed that profilin2a-binding of the mutants was not affected in W92S, E134K, Y272C and T274I mutants but significantly decreased binding in S230L (Fig. 4A) . Serine residue 230 is in close proximity to the prolin-sequence 219-224 determined as critical for profilin2a binding. The interaction of SMN and the SMN S230L mutant with profilin2a, respectively, was further analyzed in vivo by application of Förster resonance energy transfer (FRET) approach. Both, SMN and the S230L mutant, were fused with ECFP (donor), and profilin2a with EYFP (acceptor) to study their interaction in cotransfected NSC34 cells. In samples coexpressing SMN-ECFP and profilin2a-YFP we found the typical intracellular distribution (Fig. 4B) . For quantitative analysis of SMN-profilin2a interaction, we applied LuxFRET method (34) , which was recently developed in our group. Apparent FRET efficiency Ef D was calculated for different datasets at a pixel based manner (Fig. 4B, column four) . While wild-type SMN demonstrates specific interaction with profilin2a both in total cells and in neurites, the SMN S230L mutant shows significant less FRET and thus no close proximity to profilin2a (Fig.   4C ). This suggests that serine in position 230 represents an important regulatory interaction site of SMN with profilin2a.
SMN loss in SMA causes phosphorylation changes of ROCK downstream-targets
Profilin2a directly interacts with ROCK, a key player in actin regulation and neuronal differentiation (28, 35) . We hypothesized that loss of the physiological interaction of SMN with profilin2a would elicit functional changes of the ROCK pathway. First, we tested whether depletion of SMN caused any expression differences of ROCK and its downstream targets in PC12 cells. In this system, SMN expression is knocked-down by transient transfection with a shRNA vector. Experiments were carried out after 3 days of neuronal differentiation. At this point, cells are well differentiated and express neuronal markers betatubulin and neurofilament 68 (NF68) (22). Extent of knock-down was similar after 3 and 7 days, respectively, of neuronal differentiation (data not shown). After 3 days of differentiation with NGF, we detected no change in profilin2a protein expression in the extracts of shRNA expressing cells in comparison to cell extracts of the empty vector control (Fig. 5A, B) .
Similarly, protein expression of the other ROCK downstream targets LIMK1/2, cofilin and MLCP was also not affected.
Next, we analyzed whether SMN depletion had an impact on the phosphorylation of profilin2a. To detect profilin2a phosphorylation in extracts of SMN depleted PC12 cells and controls, a 2D gel electrophoresis (first dimension: isolelectric focussing, second dimension: SDS-PAGE) was performed since a phospho-profilin2a antibody was not available. The western blot revealed at least two phospho-isoforms of profilin2a with a third one occurring in SMN knock-down cells only (Fig. 6A, B) . Therefore, SMN down-regulation causes a hyperphosphorylation of profilin2a. To confirm these results in vivo we analyzed spinal cords from end stage (postnatal day 9) of a severe SMA mouse model (36, 37) . These mice express a low level of human SMN on a mouse SMN knock-out background. The results demonstrate a significant profilin2a hyperphosphorylation and confirm the results obtained from the cell culture experiments (Fig. 6C, D) .
To test whether other ROCK downstream targets are affected after down-regulation of SMN, we analyzed the phosphorylation of LIM domain kinase 1/2 (LIMK1/2) and its downstream target cofilin which binds to actin filaments. We found a significant decrease in cofilin phosphorylation after knock-down using the adequate phospho antibodies. In order to evaluate the effect of either overexpression or down-regulation of SMN in PC12 cells on another downstream target of ROCK, we used an ELISA-based system that determines the activity of ROCK by measuring the phosphorylation of the myosin-binding subunit of myosin phosphatase at threonine 696. Whereas an overexpression of SMN reduced ROCK activity significantly, the down-regulation of SMN mRNA did not influence ROCK activity compared to control conditions ( Fig S6B) . Additionally, we evaluated the phosphorylation of another interactor of ROCK, the myosin light chain phosphatase (MLCP), at two different threonine residues. Phosphorylation of threonine 696 was not changed in SMN knock-down PC12 cells or in spinal cords of postnatal day 5 (p5) and p10 SMA mice ( 
Profilin2a mutants show differential neurite extension
We aimed to analyze the consequences of profilin2a phosphorylation. Serine 137 has been described as a phosphorylation site in profilin1 (35) , which is conserved in the profilin2a sequence. To test whether the profilin2a phosphorylation has an impact on neurite outgrowth we generated the dominant-negative mutant S137A and the constitutively active, phosphomimic mutant S137D and expressed the constructs in PC12 cells. Wild-type profilin2a, S137A and S137D constructs, respectively, were coexpressed with EGFP using a vector containing an Internal Ribosomal Entry Site (IRES). Cells were differentiated for 3 days by NGF treatment and neurite lengths of EGFP-positive cells measured subsequently.
Quantification showed no statistical significant change between the mutants and the wild type.
However, neurite lengths in cells transfected with the phospho-mimic S137D mutant were significantly decreased in comparison to the non-phospho-mimic S137A mutant (Fig. 7A) .
We conclude that inhibition of neurite extension by profilin2a is dependent on phosphorylation of serine 137. The observed hyperphosphorylation of profilin2a can therefore explain our previous data demonstrating inhibition of neurite extension under SMN knockdown conditions. We tested the effect of wild-type profilin2a expression on neurite outgrowth ( (Fig. 7C ). This clearly demonstrates the importance of dysregulation of ROCK downstream targets for neurite growth defects.
SMN mutants display decreased neurite outgrowth
Next, we evaluated the effect of SMN harbouring the S230L patient mutation on neurite outgrowth. SMN mutant constructs were expressed in PC12 cells and neurite length measured after 3 days of differentiation. We have previously shown that SMN overexpression results in a significant increase of neurite growth in contrast to SMN down-regulation (22). Here we demonstrate that all selected mutations led to significant shorter neurites in comparison to wild-type SMN but also to the empty vector control (Fig. 7D ). This included a profilin2a-binding-deficient mutant of SMN (SMN [221] [222] [223] [224] [225] [226] [227] [228] ). Hence, the mutations inhibited neurite outgrowth. The strongest negative effect showed mutation S230L. This result supports that neurite defects are implicated in SMA pathogenesis.
DISCUSSION
In the present study, we demonstrated the direct interaction between SMN and the actin binding protein profilin2a using a new interaction method (TRS), which allows detection of protein interactions in a cellular system. A SMN/profilin2a interaction had been already proposed previously showing that SMN binds to profilin2a and with lower affinity to profilin1 in co-immunoprecipitation analysis using a crosslinker (32) . Profilin2a was suggested to interact with the poly proline domains spanning AS residue 195-248 of SMN (31, 32) . In our study, we showed that exclusively the second proline motif spanning residues 219-224 is critical for profilin2a binding and demonstrate for the first time a clear biological function of this region in the SMN protein. Furthermore, we determined the profilin2a binding ability of different SMA causing mutants including the newly identified mutation S230L. This site localizes adjacent to the proline stretch and specifically disrupted interaction with profilin2a in the TRS assay and in the FRET analysis. S230L affects a putative phosphorylation site which could provide a regulatory function important for profilin2a interaction. Other mutants did not display any changes in profilin2a interaction in our in vivo interaction analysis which is in contrast with a previous in vitro study showing that the ability of mutant Y272C to bind profilin2a is reduced (31) . Since this mutation also affects SMN dimerization (41) , monomers may indirectly affect profilin2a binding, whereas in our study mutants could form heterodimers with endogenous SMN and could be less sensitive against disruptions of the binding site.
How is SMN linked to the ROCK-pathway? In this study we found striking phosphorylation changes of ROCK downstream targets after knock-down of SMN or in SMA mice. Protein levels were not affected excluding the possibility of expression changes caused by SMN loss.
Upstream of the ROCK pathway small GTPases integrate growth factor signals: RhoAGTPase mediates signals from the p75 NGF-receptor by activating ROCK (42) . The other GTPases Cdc42 and Rac integrate signals by activation of the ROCK-downstream target LIM-kinase (43) . An abnormal activation of RhoA and inhibition of the Cdc42 pathway in SMN knock-down cells has been reported previously (25) . In addition, RhoA activity is increased in an intermediate SMA mouse model (26) . In this study we could not detect any changes of these small GTPases. This discrepancy may be caused by the use of different models, however, all data come to end of an abnormal increase in the ROCK pathway. We could show that the functional integration of SMN´s loss may occur at the level of ROCK:
Whereas cofilin and MLCP become hypophosphorylated, profilin2a is hyperphosphorylated if SMN levels are decreased. Profilin2a has been shown to be a direct target of ROCK (28, 35) .
The observed regulative changes are consistent with a model that employs competition between SMN and ROCK for binding to profilin2a and functionally links SMN to the ROCK pathway (Fig. 8) . The other ROCK downstream targets cofilin and MLCP become hypophosphorylated putatively by increased number of ROCK-profilin2a complexes. This is strongly supported by a previous study where an increase of profilin2a/ROCK complexes under SMN knock-down conditions compared to controls was found (25) . In the functional context of neurite outgrowth, this model is strongly supported by our observation of increased neurite length after co-expression of both profilin2a and SMN (Fig. 7B) . In contrast, profilin2a expression alone has an inhibitory effect on neurite growth. Others have found enhanced expression of profilin2a levels in a SMN-deficient PC12 cell line generated by stable transfection (25) and increased numbers of profilin2a-positive cells in spinal cord (30).
Despite the differences of the experimental systems used in the studies compared to our results, all studies show higher levels of profilin2a availability when not bound to SMN and point to the same direction.
In this study we show that hyperphosphorylation of profilin2a in SMA leads to inhibition of neurite outgrowth. However, it is unclear how profilin2a phosphorylation affects actin polymerization during neurite outgrowth. On the level of expression, increase of profilin2a inhibits actin polymerization (28, 31) . ROCK and profilin2a form a complex (25, 28) and the kinase activity of ROCK is important for regulation of profilin2a (28, 35, 44) .
Phosphorylation of profilin at serine 137 negatively regulates its affinity to G-actin (35) . At present, the location of other phospho-sites in profilin2a is unknown. ROCK inhibition, results in decreased profilin2a phosphorylation accompanied by a reduction of F-actin (28).
Thus, it can be assumed that phosphorylated profilin2a is the active form, which promotes actin polymerization at the plus end of the active filament. SMN knock-down or loss causes the opposite: hyper-phosphorylation of profilin2a and increase of F-actin. Therefore, ROCKinhibition could correct the effect of SMN reduction in SMA with regard to an adequate ratio of de-/phosphorylated profilin2a. The ROCK inhibitor Y27632 is in fact able to ameliorate the disease phenotype of SMA mice (26).
We did not observe a general change of ROCK activity and no increase of phosphorylation of other ROCK-targets, e.g. LIMK and cofilin. An increase of the inhibitory profilin2a/ROCK complex with regard to actin polymerization does not necessarily imply an increase in general ROCK activity if a competitive mechanism exists: After SMN loss, more profilin2a becomes recruited and phosphorylated by ROCK, whereas other ROCK targets are hypophosphorylated. Loss of SMN may cause a dysbalance of the system, but not induce a total change. However, addition of an inhibitor changes the situation as described above and drives the system back towards hypo-phosphorylation of profilin2a.
Cofilin and MLCP also contribute to the regulation of neurite outgrowth (45-47). Cofilin counteracts actin polymerization by binding to F-actin and promoting actin severing as well as depolymerization of the filaments. This mechanism ensures dynamics of the actin cytoskeleton at the tip of the growth cone. Cofilin phosphorylation is mediated by LIMK, which is a direct target of ROCK (Fig. 8) . LIMK phosphorylation inactivates cofilin, whereas slingshot dephosphorylates (48) . The proper balance of phosphorylation and dephosphorylation is required to regulate cofilin activity during neurite extension (46, 48) . An enhanced severing activity of cofilin in SMA increases the number of free barbed actin ends as starting points for new polymerization and could therefore explain the observed shift of the F-/G-ratio towards more F-actin. Phosphorylation of MCLP increases the amount of activated myosin II, which promotes the retrograde flow of F-actin at the tip of the growth cone (49, 50) .
In our SMA cell culture model, MLCP is hypophosphorylated which in turn may probably inhibit myosin II and thus actin dynamics. Additionally, we performed a ROCK activity assay in SMN depleted cell lysates and controls. Here, the ROCK activity was measured by phosphorylation of a peptide consisting of the myosin light chain phosphatase subunit (MBS).
Surprisingly, phosphorylation of MBS was decreased in lysates of SMN overexpressing cells, whereas no changes were detected in lysates of SMN depleted cells when compared to controls. One explanation for this could be that phosphorylation was measured using an antibody specific for phosphorylation at residue 695 which is referred to regulate catalytic activity of MLCP (51) . In contrast, the antibody we used for MLCP phosphorylation detected the phosphorylation at residue 850 which is referred to be important for MLCP-myosinbinding and predominantly phosphorylated by ROCK (39, 51) .
The ROCK pathway is a signalling hub that integrates growth factor signals and relays them to a number of downstream targets, which are involved in different actin-and myosindependent motility processes. Striking evidence for the important role of actin cytoskeleton regulation in SMA came from a study identifying the actin binding protein plastin 3 as a protective genetic modifier for SMA (52) . Interestingly, plastin 3 is functionally linked to the profilin2a/ROCK system in a SMN-dependent manner, since knock-out of profilin2a increases plastin 3 expression (30). As we showed here, interaction of SMN with profilin2a directly links SMN to the ROCK pathway. We demonstrated in a functional in vitro assay under SMN knock-down conditions that neurite outgrowth can be restored by RhoA and ROCK inhibition.
These results indicate that the ROCK pathway causes actin cytoskeletal perturbation in SMA.
Interestingly, actin regulation is important for synaptic vesicle cycling (53) and could be linked to properties observed in SMA like impaired neurotransmission (20, 54). The ROCK pathway is a potential target for pharmacological intervention in SMA. Importantly, a recent in vivo study clearly showed that inhibition of ROCK by Y27632 in an intermediate SMA mouse model dramatically improved lifespan and improved NMJ maturation defects (26) .
These data demonstrate a therapeutic potential of ROCK inhibition in SMA. These observations are consistent with our in vitro results and point towards the importance of a detailed understanding of SMN-dependent ROCK pathway regulation and actin regulation.
MATERIAL AND METHODS
Mouse strains
Mice of the strain FVB.Cg-Tg(SMN2)2Hung Smn1 tm1Hung /J (36) were obtained from the Jackson Laboratory (stock number 005058). Mice developing severe SMA symptoms were obtained following established breeding strategies (37, 55 were used for isolation of primary lumbar E14 motoneurons as described previously (57) .
Plasmid constructs
Molecular cloning of full-length human pSMN1-294-EGFP was described before (22).
pProfilin2a-IRES2-EGFP plasmid was a generous gift from Dr. A. Lambrechts and Dr. C.
Ampe, Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent
University, Belgium (58). pcDNA3-MCS-Ubc9 and pEGFP-SUMO1 were constructed as described (59, 60). Profilin2a was amplified by PCR by appropriate primers introducing EcoRI/XhoI sites and cloned into pcDNA3-MCS-Ubc9 allowing in-frame fusion with Ubc9.
Mutations were generated using the GeneTailor Site-Directed Mutagenesis System (Invitrogen) following the manufacture's protocol. All constructs were verified by sequencing.
Cell culture and transfection
NSC34, PC12 and HEK293T cells were incubated at 37°C in a 5% CO 2 atmosphere.
Immunocytochemistry and fluorescence microscopy
Cells were fixed and processed as described before (62) and mounted in Prolong Gold (Molecular Probes). Neurite length was measured as previously described (22) 
FRET measurements
Single cell confocal images were acquired using a custom tailored spinning disk setup (CSU- 
Protein interaction assays and F-/G-actin assays
For trans-SUMOylation assays (33), 5 -10 x 10 4 NSC34 cells were seeded in 12 well dishes and transfected after 12-16h with the respective constructs (300ng of the putative interaction partners; 100ng pEGFP-SUMO or unfused pSUMO). 24h after transfection, cells were directly treated with 150 µl of Laemmli buffer (80 mM Tris (pH 6.8), 2% SDS, 5% β-ME, and 0.01% bromophenol blue) and incubated for 5 min at 95 °C. 20µl of the lysates were loaded on a 10% SDS gel and subsequently analyzed by western blot. Centrifugation assays for the determination of F-/G-ratios in primary fibroblasts were performed as described before 
2D gel electrophoresis
Spinal cords from SMA mice and controls at postnatal day 9 were homogenized in RIPA analyzed by SDS-PAGE/western blot as described before (63) .
ROCK activity assay
Three days after transfection of PC12 cells with pEGFP, pSMN-EGFP, pSupp.control or pSupp.SMN, respectively, and one day after differentiation with NGF, cells were lysed with RIPA buffer. The protein content of the cell lysate samples was determined using the bicinchoninic acid assay (Pierce). The ROCK activity assay was performed according to manufacturer's instructions (CycLex, Nagano, Japan). Briefly, equal amounts of protein (50 ng) were applied to the assay plate wells and incubated with ATP-containing kinase reaction buffer at 30°C for 30 min. After washing, incubation with the HRP conjugated detection antibody was performed at room temperature for 60 min. After another washing step, the tetramethylbenzidine containing substrate reagent was added and incubated at room temperature for 10 min until the reaction was stopped with 0.25 M sulphuric acid. Absorbance was measured in a Tecan spectrophotometric plate reader (Tecan, Crailsheim, Germany) at 450 nm single wavelength.
Pull-down assay
Pull down experiments were performed as described before (64) . PC12 cells were grown in culture flasks (150 cm²) and SMN knockdown was performed as described above. leads to an increase of the inhibitory activity of profilin2a with regard to neurite outgrowth regulation and putatively other motility processes.
